Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR - PubMed (original) (raw)
Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR
Nirosha Suraweera et al. Gastroenterology. 2002 Dec.
Abstract
Background & aims: The microsatellite instability (MSI) phenotype is a characteristic of the hereditary nonpolyposis colorectal cancer syndrome as well as approximately 15% of sporadic colon and gastric tumors. It is a valuable diagnostic marker for the identification of hereditary nonpolyposis colorectal cancer cases and may be a molecular predictive marker for the identification of colon cancer patients who benefit from chemotherapy. To evaluate MSI, a reference panel was proposed at an international consensus meeting, comprised of 2 mononucleotide (BAT-25, BAT-26) and 3 dinucleotide repeats. Analysis of BAT-26 is sufficient for detecting the MSI phenotype in most, but not all, cases. Additional results with dinucleotide markers can sometimes lead to incorrect classification of MSI tumors.
Methods: We describe here a single fluorescent multiplex system comprising 5 quasimonomorphic mononucleotide repeats for the detection of MSI tumors.
Results: None of 184 germline DNA samples, including 56 from African subjects, was found to contain allelic size variations in more than 2 of these markers. In contrast, all MSI tumors showed allelic size variations in 3 or more of the microsatellites. Using this assay, we confirmed (or reclassified in 6 cases) the MSI status of 124 colon and 50 gastric primary tumors and 16 colon cell lines.
Conclusions: We propose that using a pentaplex polymerase chain reaction system allows accurate evaluation of tumor MSI status of DNA with 100% sensitivity and specificity without the need to match normal DNA. This assay is simpler to use than those involving dinucleotides and is more specific than using BAT-26 alone.
Similar articles
- Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers.
Wong YF, Cheung TH, Lo KW, Yim SF, Chan LK, Buhard O, Duval A, Chung TK, Hamelin R. Wong YF, et al. Carcinogenesis. 2006 May;27(5):951-5. doi: 10.1093/carcin/bgi333. Epub 2006 Feb 20. Carcinogenesis. 2006. PMID: 16490738 - Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis.
Buhard O, Suraweera N, Lectard A, Duval A, Hamelin R. Buhard O, et al. Dis Markers. 2004;20(4-5):251-7. doi: 10.1155/2004/159347. Dis Markers. 2004. PMID: 15528790 Free PMC article. Review. - Development of a fluorescent multiplex assay for detection of MSI-High tumors.
Bacher JW, Flanagan LA, Smalley RL, Nassif NA, Burgart LJ, Halberg RB, Megid WM, Thibodeau SN. Bacher JW, et al. Dis Markers. 2004;20(4-5):237-50. doi: 10.1155/2004/136734. Dis Markers. 2004. PMID: 15528789 Free PMC article. - Simplified MSI marker panel for diagnosis of colorectal cancer.
Shemirani AI, Haghighi MM, Zadeh SM, Fatemi SR, Taleghani MY, Zali N, Akbari Z, Kashfi SM, Zali MR. Shemirani AI, et al. Asian Pac J Cancer Prev. 2011;12(8):2101-4. Asian Pac J Cancer Prev. 2011. PMID: 22292659 - Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer.
Siah SP, Quinn DM, Bennett GD, Casey G, Flower RL, Suthers G, Rudzki Z. Siah SP, et al. Breast Cancer Res Treat. 2000 Mar;60(2):135-42. doi: 10.1023/a:1006315315060. Breast Cancer Res Treat. 2000. PMID: 10845276 Review.
Cited by
- Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.
Trembath HE, Yeh JJ, Lopez NE. Trembath HE, et al. Cancer Treat Res. 2024;192:305-418. doi: 10.1007/978-3-031-61238-1_15. Cancer Treat Res. 2024. PMID: 39212927 Review. - Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants.
Gallon R, Brekelmans C, Martin M, Bours V, Schamschula E, Amberger A, Muleris M, Colas C, Dekervel J, De Hertogh G, Coupier J, Colleye O, Sepulchre E, Burn J, Brems H, Legius E, Wimmer K. Gallon R, et al. NPJ Precis Oncol. 2024 May 24;8(1):119. doi: 10.1038/s41698-024-00603-z. NPJ Precis Oncol. 2024. PMID: 38789506 Free PMC article. - One-instrument, objective microsatellite instability analysis using high-resolution melt.
Bendixen KK, Forsberg-Pho S, Dazio G, Hansen EE, Eriksen SK, Epistolio S, Merlo E, Boldorini R, Venesio T, Movilia A, Caprera C, Arnspang EC, Børgesen M, Christensen UB, Frattini M, Petersen RK. Bendixen KK, et al. PLoS One. 2024 Apr 25;19(4):e0302274. doi: 10.1371/journal.pone.0302274. eCollection 2024. PLoS One. 2024. PMID: 38662796 Free PMC article. - Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T, Huang X, Liu W, Ling X, Su Z, Huang M, Che S. Zhang T, et al. Diagn Pathol. 2024 Jan 31;19(1):25. doi: 10.1186/s13000-024-01447-8. Diagn Pathol. 2024. PMID: 38297350 Free PMC article. - MLH1 Promoter Methylation Could Be the Second Hit in Lynch Syndrome Carcinogenesis.
Carnevali IW, Cini G, Libera L, Sahnane N, Facchi S, Viel A, Sessa F, Tibiletti MG. Carnevali IW, et al. Genes (Basel). 2023 Nov 9;14(11):2060. doi: 10.3390/genes14112060. Genes (Basel). 2023. PMID: 38003003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources